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Abstract
Background: Haemangiomas of the head or face are a frequent vascular pathology, consisting in
an embryonic dysplasia that involves the cranial-facial vascular network. Haemangiomas show
clinical, morphological, developmental and structural changes during their course.
Methods: The clinical characteristics of head-facial haemagiomas were studied in 28 individuals (9
males and 19 females) admitted in our Hospital. Sixteen of these patients(n = 16) underwent
surgery for the removal of the haemangiomas. All the removed tissues were transferred in
experimental laboratories for the staining of microanatomical details, somatic and visceral nerve
fibres, adrenergic and catecholaminergic nerve fibres. Beta-adrenergic receptors were died with a
fluorescent method. All results were submitted to the quantitative analysis of images and statistical
evaluation of the data.
Results: The morphological results revealed numerous micro-anatomical characteristics of the
haemangiomatous vessels. The somatic and visceral nerve fibres were poor and located exclusively
in the adventitial layer. There was a marked decrease of adrenergic nerve fibres in the
haemangiomatous vessels. The fluorescence of catecholaminergic nerve fibres and the overall area
of fluorescent structures were also decreased in haemangiomatous vessels. Beta adrenergic
receptors are strongly decreased in haemangiomatous vessels. The morphometrical analysis of
images and statistical evaluation of the data confirmed all our experimental results.
Conclusion:  The catecholaminergic innervation of the human haemangiomatous vessels
comprises nerve fibres containing the main catecholaminergic neurotransmitters that are
sympathetic in nature. These neurotransmitters are closely related to beta-adrenergic receptors.
The sympathetic nervous system plays a key role in the control of the vascular bed flow and 
vascular motility in both normal and haemangiomatous vessels.
Background
A bibliographic research on med-line for the word "hae-
mangioma " yields 1440 references in the last three years
(2004–2006). The association of the term "head-facial"
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strongly reduces this number. The addition of the term
"nervous system" further reduces the number of refer-
ences to a mere seven. None of these seven references con-
cerns the catecholaminergic innervation of
haemangiomas. Haemangiomas are benign lesions of
blood vessels that faithfully create well formed vascular
channels. Usually present from birth, they may represent
congenital hamartomas or benign neoplasms arising in a
congenital defect [1]. In the newborn, they may be so
small as to be in-visible. These lesions are considered by
many researchers to be hamartomas that grow as the body
develops [2]. However, these lesions may even arise spon-
taneously as true neoplasms in children or adults [3]. As
the body grows, these masses become highly visible
becoming several centimetres in diameter. In many
instances, they cease to enlarge and enter a period of
apparent dormancy [4]. Although haemangiomas are usu-
ally of little clinical relevance, when present in the brain,
they are potential sources of increased intra-cranial pres-
sure or haemorrhage. Malignant transformation of a cav-
ernous haemangioma is an extremely rare occurrence [5].
The venous wall ultra-structure in generalized venomeg-
aly and/or arteromegaly was studied in our laboratories
from many years [6,7], including the sympathetic innerva-
tion of the mega-vessels [8]. Cunha and co-workers stud-
ied, with histochemical, immunohistochemical and
ultrastructural methods, the innervation of malformative
cortical vessels in Sturge-Weber disease. These authors
suggested that the abnormal vessels were innervated
exclusively by noradrenergic sympathetic nerve fibres [9].
Since little is known about the innervation of haemangi-
omas, although adrenergic receptors are known to play a
role in the occurrence and healing of haemangiomas, the
aim of this study was to shed light on the catecholaminer-
gic and adrenergic nerve fibres and the beta-adrenergic
receptors of the haemangiomas.
Materials and methods
The Clinical units of Plastic Surgery, Maxillo-Facial Sur-
gery and Neurotraumatology of our University enrolled,
in the last five years, 28 patients with cranio-facial hae-
mangiomas (n = 28). All the patients were studied for clin-
ical or diagnostic reasons. Table 1 contains basic
information of the patients such as age and sex. All the
patients underwent a thorough clinical study. Every case
was evaluated with ultrasound imaging, CT and MRI to
obtain a complete diagnostic study. In presence of urgent,
complex lesions that would need a more aggressive treat-
ment the therapy was planned in collaboration with other
Clinical Units involved in these studies. All the lesions
were recorded according to photographic and objective
clinical evidence. The following therapies were used:-
embolism – laser therapy – other surgical techniques [10].
The laser used was an ND: YAG laser (neodymium
:yttirium-aluminium-garnet) used with fluorescence of
400–600 J/cm2 with pulse duration of 0,5 sec. These set-
tings were selected on the basis of good results in litera-
ture [11-15].
The surgical techniques varied according to lesion exten-
sion and location. Serial or simple excision was per-
formed. If necessary the reconstruction of the ablated
tissues was performed with local or microsurgical flaps.
An immediate post-surgical and 3-6-12 month follow-ups
was performed and documented.
16 patients were underwent conventional surgical therapy
for the removal of haemangiomas and fresh samples of
removed tissues were studied in our experimental labora-
tories. As mentioned previously, samples of the hemangi-
omatous vessels were obtained from haemangiomas
removed in case of open surgery avoiding of course any
potential risk for the patients, all procedures were in
accordance with the ethical standards of the responsible
Committee on human experimentation and with the Dec-
Table 1: Clinical data on patients enrolled in the present experiment
Patient Sex Age Operated Patient SEX Age Operated
1M 5 4 Y E S 1 5 M 8 2 N O
2F4 9 Y E S 1 6 F7 7 N O
3M 2 8 N O 1 7 M 5 8 Y E S
4M 3 4 N O 1 8 M 5 0 Y E S
5 M 56 YES 19 M 54 YES
6F4 2 Y E S 2 0 F7 2 N O
7F4 0 Y E S 2 1 F7 6 N O
8F7 9 N O 2 2 F5 4 Y E S
9M 6 6 N O 2 3 M 4 2 Y E S
1 0M 5 8Y E S 2 4M 4 0Y E S
1 1M 5 6Y E S 2 5M 4 6Y E S
1 2M 6 2Y E S 2 6M 4 8Y E S
1 3F 6 0Y E S 2 7F 5 2Y E S
1 4F 7 8N O 2 8F 5 4Y E SHead & Face Medicine 2007, 3:12 http://www.head-face-med.com/content/3/1/12
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laration of Helsinki (1964) of the World Medical Associa-
tion (amended in 1988) [16]. As "normal" vessels we used
small samples of vessels of the same patient, and in the
same zone, considered as normal after an accurate exami-
nation.
The fresh material was fixed, dehydrated, paraffin-embed-
ded and cut for morphological staining. The microana-
tomical details were displayed using the hematoxylin-
eosin as dye, as usual in morphological laboratories [17].
Moreover, all somatic and visceral nerve fibers were
stained using the method of Bodian [18]. This method
can be used to verify that a stained structure is nervous in
nature. In fact, it stains all nerve fibres and neuro-fibrils.
The adventitia was separated with scissors from other lay-
ers and stretched on a slice. After fixation, the sections
were treated with: 1) 1% Protargol solution (colloidal sil-
ver), 2) reducing solution (Hydroquinone + sodium sul-
phite), 3) 1% Gold chloride solution, 4) 2% oxalic acid
solution and counterstained with 0.03% aniline blue. The
nerve fibers and neuro-fibrils are stained in black.
Other fresh samples were refrigerated and preserved until
use. On these samples we performed the staining of the
adrenergic nerve fibres (ANF) by Falck technique, using
the fluorescence induced by formaldehyde vapours [19]
and/or with glyoxylic acid technique (GIF) for cate-
colaminergic nerve fibres [20] Moreover, on fresh samples
we performed also the staining of adrenergic recep-
tors[21]. ANF staining : Small samples can be dissected
and treated to reveal adrenergic nerve fibres under formal-
dehyde vapours. After staining, samples can be examined
by fluorescence microscopy using a Carl Zeiss photomi-
croscope (PMQ-II; Jena; Germany) provided with an epi-
illumination system for fluorescence observations.
Samples are photographed using black and white pan F18
DIN film. The a-specific fluorescence can be barred with
special filters.
A glyoxylic acid-induced fluorescence technique is used
for the staining of catecholaminergic nerve fibres (CNF)
(20). Briefly, immediately before the use the staining solu-
tion can be prepared by adding a solution of 0.236 M
potassium phosphate (pH 7.4) 0.2 M sucrose and 1% gly-
oxylic acid.
This staining is named sucrose, phosphate, glyoxylic acid
(SPG). The slides with samples can be immediately
dipped in this solution for 5 min. To assure a comparable
fluorescence it is important to standardize times and tem-
peratures without intervals. After staining, the sections
must be drained, covered with non-autofluorescent
immersion oil, heated at 95°C for 5 min., observed and
photographed to prevent diffusion and photodecomposi-
tion of the fluorescence. The sections can be examined
and photographed under a Zeiss photomicroscope
equipped with exciter and barrier filters and with a mer-
cury lamp for observation of fluorescence.
Beta-adrenergic receptors staining: The location of beta-
adrenergic receptors in the wall of angiomatous vessels is
identified by fluorescent staining using a beta-blocker
drug (Pindolol-Visken LB 46 Sandoz Basilea CH) conju-
gated with a fluorochrome (fluoresceine isothiocyanate =
FITC). The biological activity of the fluorescent pindolol
(FPIN) has been previously tested both "in vitro" and "in
vivo", by studying its cardio-vascular activity and dosing
the nor-epinephrine-dependent adenilate-cyclase. After
binding, the pharmacological effect of FPIN is reduced by
30%. FPIN can be used to locate beta-adrenergic receptors
on fresh-cut sections of human angiomatous vessels. The
specificity of this reaction has been previously assessed
pre-treating some sections with non-fluorescent pindolol
and then exposing them to FPIN or by treating samples
with reaction-inhibiting agents. We used propanolol
(which blocks both b1 and b2 receptors) [22], ICI 118
551 (which blocks b2 receptors alone) [23] and CGP
20712A (which blocks only b1 receptors) [24]. The sec-
tions were stretched on a microscope slide and treated for
30' at room temperature with the afore-mentioned beta-
blocker substance conjugated with fluoresceine isothiocy-
anate (FITC). Thereafter the samples were washed, for 10',
in an isotonic solution of 10% polyvinylpyrrolidone
(PVP), thermostat dried at 37% and mounted in a water-
soluble medium. The corners of the covering slide were
treated with boiling paraffin and enamelled. Observations
were performed under a U.V. Zeiss photomicroscope
using the following combinations of exciting and barrier
filters: UG1 with 41/44 and BG12 with 53/44.
To stain the sections it is possible to use either an anti
beta-blocker antibody conjugated with FITC or a beta-
blocker conjugated, directly, with FITC. As the results
yielded, in the first case we observed less evident results,
we recommend the use of fluorescent staining with the
beta-blocker conjugated with FITC.
Quantitative analysis of images (QAI). In order to evalu-
ate the amount of staining, a quantitative analysis of the
intensity of the histofluorescent staining can be per-
formed on photographs (to avoid photodecomposition)
by means of a Quantimet Analyzer (Leica). The control
values from samples incubated without fluorochrome,
were considered as "zero". The following parameters can
be measured 1)total area of fluorescent structures,
2)number of nervous varicosities, 3)number of crossings
or intersections of nerve fibres. All these values can be
expressed as conventional unit (C.U.). Each photograph
can be examined separately by calculating the standardHead & Face Medicine 2007, 3:12 http://www.head-face-med.com/content/3/1/12
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error of the mean (=S.E.M.). The final values undergo sta-
tistical analysis. The values reported in our experiments
represent the intensity of staining for each type of tissue
and are expressed in conventional units (C.U.) ± SEM.
Further details on QAI are reported in Manual of the
Quantimet Leica 500 image analyser [25]
Statistical analysis
To ascertain the significance of QAI, standard Error of
Mean (SEM), probability index (p) and Student t' test
were performed.
Results
Clinical studies we conducted showed that the vascular
bed of haemangioma is connected to the surrounding
blood vessels through a solitary afferent and efferent
channel. This interesting finding explains why spontane-
ous or induced thrombosis of the connecting vessels may
lead to thrombosis of the whole haemangioma with con-
sequent obliteration of the lumen of the entire lesion.
On samples coming from surgical theatre, as said above,
we performed numerous experiments. The following
micro-anatomical details emerged from the haematox-
iline-eosin staining: the mass of the haemangiomas is
sharply defined, but not encapsulated, and made up of
large, cavernous, vascular space, partly or completely
filled with fluid blood separated by a scant connective tis-
sue stroma. Intra-vascular thrombosis or rupture of chan-
nels may modify its histologic appearance (Fig, 1).
Bodian' s method stains all somatic and visceral nervous
structures. Our results demonstrate that the nerve fibres in
haemagiomatous vessels are poor and located in adventi-
tial layer, while the medium layer and the endothelial
layer are about devoid of nerve fibres (Fig. 2A and 2B).
The haemangiomatous vessels were found to contain a
number of ANF located in the adventitial layer. The other
layer of the haemangiomatous vessels are about devoid of
ANF. The total area of fluorescent structures is smaller,
and the number of nervous varicosities, crossings and
intersections of nerve fibres is lower in haemangiomatous
vessels than in normal vessels (Fig. 3A and 3B; Table 2).
Catecholaminergic nerve fibers were stained by means of
Qayyum's method, using GIF induced fluorescence. Few
nerve fibres in haemangiomatous vessels displayed GIF
induced fluorescence. There was a lower number of cate-
chola-minergic nerve fibres in haemangiomatous vessels
than in normal vessels (Fig. 4A and 4B; Table 2).
Beta adrenergic receptors were stained by means of a
fluoro-chrome linked to a beta adrenergic drug. Although
beta-adrenergic receptors were found in both normal and
haemangiomatous vessels, in the latter they were present
in a decreased concentration and only in the adventitial
layer (Fig. 5A and 5B; Table 2).
QAI yelded the morphometrical results listed in Table 2.
As shown, the haemangiomatous vessels contained, in the
whole wall, approximately 30% of the nerve fibres found
in normal vessels. The majority of these nerve fibres were
catecholaminergic and/or adrenergic, in nature. The beta-
adrenergic receptors were strongly decreased in haemangi-
omatous vessels (about 30% than in normal vessels).
The statistical analysis showed that our results were signif-
icant, (<0.001, Table 2).
Discussion
In normal blood-vessels nerve fibres are distributed in all
the three layers of vascular wall (endothelium, smooth
muscle medium layer, adventitia) in the hemangiomas
the distribution of nerve fibres is lower than in normal
conditions and nerve fibres are localized only in the
adventitia, while the medium and the endothelial layers
are about free of nerve fibres.
Moreover our results show that beta adrenergic receptors
are evenly distributed in the wall of normal vessels, but
unevenly distributed In the wall of the hemangiomatous
vessels. There are fewer receptors than in normal tissues
and located exclusively in the adventitia, while the
medium and the endothelial layers are about free of beta-
adrenergic receptors.
The research of specific markers [26] in rare head-facial
syndromes can be helpful also for the identification of
genes responsible of these diseases. Recently much
progress has been made in the identification of genes
responsible for rare head-facial syndromes. This has
resulted in the ability to diagnose an increasing number of
head-facial syndromes in the neonatal period by molecu-
lar genetic analysis. However, at the present time genetic
testing for many of these conditions is only available from
a small number of research laboratories. Transfer of
genetic testing to diagnostic laboratories may make
genetic testing more widely available but the costs of anal-
ysis are likely to be significant and may prevent accessibil-
ity to confirmatory genetic testing in many situations.
Newer, more rapid and, hopefully, cheaper techniques of
mutation analysis may make accessibility to genetic test-
ing more widely available.
Our results on the sympathetic nerve fibres of the hae-
mangiomatous vessels can be useful for the studies of spe-
cific sympathetic markers and their specific genes.Head & Face Medicine 2007, 3:12 http://www.head-face-med.com/content/3/1/12
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Light microscopy of haemangiomatous vessels of the face stained with haematoxyline-eosine revealing micro-anatomical details Figure 1
Light microscopy of haemangiomatous vessels of the face stained with haematoxyline-eosine revealing micro-anatomical 
details. A = artery; V = vein; N = nerve. Both the endothelial and medium layers of the artery wall are uneven discontinuous 
and non homogeneous (magnification 100×; bar 100 μm).Head & Face Medicine 2007, 3:12 http://www.head-face-med.com/content/3/1/12
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A and B. Fluorescent light microscopy of a transversal section of a normal (A) artery of the face stained using Falck's method  for the staining of adrenergic nerve fibers compared with a haemangiomatous artery (B) Figure 3
A and B. Fluorescent light microscopy of a transversal section of a normal (A) artery of the face stained using Falck's method 
for the staining of adrenergic nerve fibers compared with a haemangiomatous artery (B). A = adventitia; M = medium layer; E = 
endothelial layer; L = lumen (magnification 400×; bar 100 μm).
A and B. Light microscopy of total nerve fibers in a normal (A) and haemangiomatous (B) artery of the face stained using  Bodian's method Figure 2
A and B. Light microscopy of total nerve fibers in a normal (A) and haemangiomatous (B) artery of the face stained using 
Bodian's method. The adventitia was separated from other layers of the artery wall and stretched on a slice. As can be seen, 
there are fewer nerve fibers in the haemangiomatous artery (B) than in the normal artery (A) (magnification 400×; bar 100 
μm).Head & Face Medicine 2007, 3:12 http://www.head-face-med.com/content/3/1/12
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A and B. Fluorescent light microscopy of a transversal section of a normal (A) artery of the face stained using Qayyum's  method, which stains the catecholaminergic nerve fibers Figure 4
A and B. Fluorescent light microscopy of a transversal section of a normal (A) artery of the face stained using Qayyum's 
method, which stains the catecholaminergic nerve fibers. Results are compared with an analogue image from an haemangioma-
tous artery (B) A = adventitia; M = medium layer; L = lumen (magnification 400×; bar 100 μm).
Table 2: Quantitative Analysis of images with statistical evaluation of the data of total, catecholaminergic, adrenergic nerve fibers (n. 
f.) and/or Beta-adrenergic receptors in the haemangiomatous and normal vessels.
QAI results Haemangiomatous vessels Normal vessels
Total n. f. 31.4 ± 2.8* 96.3 ± 3.1
Catecholaminergic n. f. 27.6 ± 3.3* 48.3 ± 2.8
Adrenergic n. f. 12.9 ± 2.8* 21.6 ± 3.2
Beta-adrenergic receptors 39.8 ± 3.2* 95.6 ± 3.6
All the results are expressed as C.U. (Conventional Units) ± SEM.
* P < 0.001 versus normal.Head & Face Medicine 2007, 3:12 http://www.head-face-med.com/content/3/1/12
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A and B. Fluorescent light microscopy of beta-adrenergic receptors contained in a transversal section of a normal (A) and an  haemangioma-tous (B) artery of the face stained with fluorescent pindolole Figure 5
A and B. Fluorescent light microscopy of beta-adrenergic receptors contained in a transversal section of a normal (A) and an 
haemangioma-tous (B) artery of the face stained with fluorescent pindolole. The beta adrenergic receptors in the haemangi-
omatous arteries are located exclusively in the adventitia, while they lack in other layers. A = adventitia; L = lumen(magnifica-
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